Peptides Academy
Cartalax
Research-Grade
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the Khavinson bioregulator family, designed to target cartilage and musculoskeletal tissue. It is the synthetic analog derived from cartilage tissue extracts and is proposed to regulate chondrocyte gene expression. In preclinical studies, Cartalax has demonstrated effects on chondrocyte proliferation, glycosaminoglycan synthesis, and extracellular matrix maintenance. In aging animal models, it has been associated with preservation of cartilage integrity and reduced degenerative changes in joint tissue. The musculoskeletal bioregulator approach is relevant because osteoarthritis — the most common joint disease — is fundamentally driven by imbalanced cartilage metabolism where degradation exceeds synthesis. Cartalax aims to restore the synthetic capacity of aging chondrocytes at the gene-expression level.
Specifications
| Origin / Manufacturer | Synthetic |
| Active Components | Cartalax tripeptide (Ala-Glu-Asp)Mannitol (capsule filler) |
| Storage | Room temperature, protected from moisture |
| Shelf Life | 36 months |
| Form Factor | Capsules (10 mg) |
Frequently Asked Questions
Related Peptides
BPC-157
Research-Grade
A 15-amino-acid peptide fragment derived from gastric juice protein BPC, studied extensively in animal models for tissue healing and gut integrity.
Hydrolyzed Collagen Peptides
Various (Supplement)
Enzymatically hydrolyzed collagen broken into short peptides that survive digestion — marketed for skin, joint, and connective-tissue support.
Pentosan Polysulfate (PPS)
Prescription
A semi-synthetic glycosaminoglycan with anticoagulant and anti-inflammatory properties, FDA-approved for interstitial cystitis and studied for osteoarthritis cartilage protection.
TB-500 (Thymosin β4 Fragment)
Research-Grade
Synthetic fragment of Thymosin β4 investigated for actin-binding, cell migration, and tissue repair across muscle, cornea, and cardiac models.